{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:07:20Z","timestamp":1785496040367,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-021-06384-1","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:03:45Z","timestamp":1643018625000},"page":"913-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Trends, characteristics, and outcomes of conservative management for placenta percreta"],"prefix":"10.1007","volume":"306","author":[{"given":"Ariane C.","family":"Youssefzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rauvynne N.","family":"Sangara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Bainvoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Ouzounian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"issue":"6","key":"6384_CR1","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2018.09.042","volume":"219","author":"Society of Gynecologic Oncology","year":"2018","unstructured":"Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists et al (2018) Placenta accreta spectrum. Am J Obstet Gynecol 219(6):B2\u2013B16","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"6384_CR2","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","volume":"378","author":"RM Silver","year":"2018","unstructured":"Silver RM, Branch DW (2018) Placenta accreta spectrum. N Engl J Med 378(16):1529\u20131536","journal-title":"N Engl J Med"},{"issue":"5","key":"6384_CR3","doi-asserted-by":"publisher","first-page":"534.e1","DOI":"10.1016\/j.ajog.2021.04.233","volume":"225","author":"S Matsuzaki","year":"2021","unstructured":"Matsuzaki S, Mandelbaum RS, Sangara RN et al (2021) Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. Am J Obstet Gynecol. 225(5):534.e1\u2013534.e38","journal-title":"Am J Obstet Gynecol."},{"issue":"Suppl 1","key":"6384_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/aogs.14096","volume":"100","author":"HJ van Beekhuizen","year":"2021","unstructured":"van Beekhuizen HJ, Stefanovic V, Schwickert A et al (2021) A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum. Acta Obstet Gynecol Scand 100(Suppl 1):12\u201320","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2 Pt 1","key":"6384_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/AOG.0b013e3181ad9442","volume":"114","author":"CS Shellhaas","year":"2009","unstructured":"Shellhaas CS, Gilbert S, Landon MB et al (2009) The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol 114(2 Pt 1):224\u2013229","journal-title":"Obstet Gynecol"},{"issue":"3","key":"6384_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ajog.2020.01.044","volume":"223","author":"JC Kingdom","year":"2020","unstructured":"Kingdom JC, Hobson SR, Murji A et al (2020) Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020. Am J Obstet Gynecol 223(3):322\u2013329","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"6384_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ijgo.12411","volume":"140","author":"S Matsuzaki","year":"2018","unstructured":"Matsuzaki S, Yoshino K, Endo M, Kakigano A, Takiuchi T, Kimura T (2018) Conservative management of placenta percreta. Int J Gynaecol Obstet 140(3):299\u2013306","journal-title":"Int J Gynaecol Obstet"},{"key":"6384_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejogrb.2019.09.017","volume":"244","author":"E Licon","year":"2020","unstructured":"Licon E, Matsuzaki S, Opara KN et al (2020) Treatment and outcome of placenta percreta: primary cesarean hysterectomy versus conservative management. Eur J Obstet Gynecol Reprod Biol 244:201\u2013203","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"6384_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/GRF.0000000000000395","volume":"61","author":"L Sentilhes","year":"2018","unstructured":"Sentilhes L, Kayem G, Silver RM (2018) Conservative management of placenta accreta spectrum. Clin Obstet Gynecol 61(4):783\u2013794","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"6384_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/uog.14728","volume":"46","author":"M Teixidor Vinas","year":"2015","unstructured":"Teixidor Vinas M, Belli AM, Arulkumaran S, Chandraharan E (2015) Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the triple-P procedure. Ultrasound Obstet Gynecol 46(3):350\u2013355","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"6384_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijgo.2011.12.005","volume":"117","author":"E Chandraharan","year":"2012","unstructured":"Chandraharan E, Rao S, Belli AM, Arulkumaran S (2012) The triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet 117(2):191\u2013194","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"6384_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1600-0412.2012.01451.x","volume":"92","author":"C Clausen","year":"2013","unstructured":"Clausen C, Stensballe J, Albrechtsen CK, Hansen MA, Lonn L, Langhoff-Roos J (2013) Balloon occlusion of the internal iliac arteries in the multidisciplinary management of placenta percreta. Acta Obstet Gynecol Scand 92(4):386\u2013391","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"6384_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/AOG.0b013e3181d066d4","volume":"115","author":"L Sentilhes","year":"2010","unstructured":"Sentilhes L, Ambroselli C, Kayem G et al (2010) Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 115(3):526\u2013534","journal-title":"Obstet Gynecol"},{"issue":"6","key":"6384_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ajog.2015.04.034","volume":"213","author":"KA Fox","year":"2015","unstructured":"Fox KA, Shamshirsaz AA, Carusi D et al (2015) Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol 213(6):755\u2013760","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6384_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/aogs.12295","volume":"93","author":"C Clausen","year":"2014","unstructured":"Clausen C, Lonn L, Langhoff-Roos J (2014) Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand 93(2):138\u2013143","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"6384_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/ajo.12149","volume":"54","author":"S Pather","year":"2014","unstructured":"Pather S, Strockyj S, Richards A, Campbell N, de Vries B, Ogle R (2014) Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. Aust N Z J Obstet Gynaecol 54(1):84\u201387","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"6384_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00404-014-3496-x","volume":"291","author":"A Shabana","year":"2015","unstructured":"Shabana A, Fawzy M, Refaie W (2015) Conservative management of placenta percreta: a stepwise approach. Arch Gynecol Obstet 291(5):993\u2013998","journal-title":"Arch Gynecol Obstet"},{"issue":"11","key":"6384_CR18","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00270-016-1418-y","volume":"39","author":"Q Wu","year":"2016","unstructured":"Wu Q, Liu Z, Zhao X et al (2016) Outcome of pregnancies after balloon occlusion of the infrarenal abdominal aorta during caesarean in 230 patients with placenta praevia accreta. Cardiovasc Intervent Radiol 39(11):1573\u20131579","journal-title":"Cardiovasc Intervent Radiol"},{"key":"6384_CR19","unstructured":"Overview of the National (Nationwide) Inpatient Sample (NIS). https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp. Accessed 8 Jan 2021"},{"key":"6384_CR20","unstructured":"Soni A, Fingar KR, Reid LD. Obstetric delivery inpatient stays involving substance use disorders and related clinical outcomes. HCUP Statistical Brief #254. Rockville, MD, October 2019. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb254-Delivery-Hospitalizations-Substance-Use-Clinical-Outcomes-2016.jsp. Accessed 20 July 2021"},{"key":"6384_CR21","unstructured":"Centers for Disease Control and Prevention. How does CDC identify severe maternal morbidity? https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/smm\/severe-morbidity-ICD.htm. Accessed 20 July 2021"},{"key":"6384_CR22","unstructured":"Defining Adult Overweight and Obesity. Centers for disease control and prevention. https:\/\/www.cdc.gov\/obesity\/adult\/defining.html. Accessed 20 July 2021"},{"issue":"2","key":"6384_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ije\/dyw040","volume":"45","author":"S Greenland","year":"2016","unstructured":"Greenland S, Daniel R, Pearce N (2016) Outcome modelling strategies in epidemiology: traditional methods and basic alternatives. Int J Epidemiol 45(2):565\u2013575","journal-title":"Int J Epidemiol"},{"key":"6384_CR24","unstructured":"Severe Maternal Morbidity in the United States. Centers for disease control and prevention. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/severematernalmorbidity.html. Accessed 1 Aug 2021"},{"issue":"6","key":"6384_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","volume":"156","author":"AA Ghaferi","year":"2021","unstructured":"Ghaferi AA, Schwartz TA, Pawlik TM (2021) STROBE reporting guidelines for observational studies. JAMA Surg 156(6):577\u2013578","journal-title":"JAMA Surg"},{"issue":"22","key":"6384_CR26","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1080\/14767058.2017.1359535","volume":"31","author":"C Kilicci","year":"2018","unstructured":"Kilicci C, Ozkaya E, Eser A et al (2018) Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta. J Matern Fetal Neonatal Med 31(22):2935\u20132940","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"6384_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ijgo.12308","volume":"140","author":"MS Kutuk","year":"2018","unstructured":"Kutuk MS, Ak M, Ozgun MT (2018) Leaving the placenta in situ versus conservative and radical surgery in the treatment of placenta accreta spectrum disorders. Int J Gynaecol Obstet 140(3):338\u2013344","journal-title":"Int J Gynaecol Obstet"},{"issue":"18","key":"6384_CR28","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1080\/14767058.2016.1240163","volume":"30","author":"PV Pinto","year":"2017","unstructured":"Pinto PV, Machado AP, Montenegro N (2017) Risk of hemorrhage in abnormally invasive placenta according to its management. J Matern Fetal Neonatal Med 30(18):2139\u20132145","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"Suppl 1","key":"6384_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/aogs.14103","volume":"100","author":"A Schwickert","year":"2021","unstructured":"Schwickert A, van Beekhuizen HJ, Bertholdt C et al (2021) Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): a multinational database study. Acta Obstet Gynecol Scand 100(Suppl 1):29\u201340","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"6384_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.tjog.2017.04.016","volume":"56","author":"HW Su","year":"2017","unstructured":"Su HW, Yi YC, Tseng JJ et al (2017) Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol 56(3):353\u2013357","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"21","key":"6384_CR31","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1080\/14767058.2018.1465918","volume":"32","author":"MS Kutuk","year":"2019","unstructured":"Kutuk MS, Kilic A, Ak M, Ozgun M (2019) Infectious complications in morbidly adherent placenta treated with leaving placenta in situ: a cohort series and suggested approach. J Matern Fetal Neonatal Med 32(21):3520\u20133525","journal-title":"J Matern Fetal Neonatal Med"},{"key":"6384_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bpobgyn.2020.07.010","volume":"72","author":"L Sentilhes","year":"2021","unstructured":"Sentilhes L, Kayem G, Mattuizzi A (2021) Conservative approach: intentional retention of the placenta. Best Pract Res Clin Obstet Gynaecol 72:52\u201366","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"6384_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ajog.2014.11.018","volume":"212","author":"RM Silver","year":"2015","unstructured":"Silver RM, Fox KA, Barton JR et al (2015) Center of excellence for placenta accreta. Am J Obstet Gynecol 212(5):561\u2013568","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6384_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajog.2014.08.019","volume":"212","author":"AA Shamshirsaz","year":"2015","unstructured":"Shamshirsaz AA, Fox KA, Salmanian B et al (2015) Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 212(2):218 (e211\u2013e219)","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"6384_CR35","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.0001-6349.2004.00517.x","volume":"83","author":"JM Palacios Jaraquemada","year":"2004","unstructured":"Palacios Jaraquemada JM, Pesaresi M, Nassif JC, Hermosid S (2004) Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstet Gynecol Scand 83(8):738\u2013744","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"6384_CR36","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.crad.2012.04.001","volume":"67","author":"A Bouvier","year":"2012","unstructured":"Bouvier A, Sentilhes L, Thouveny F et al (2012) Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. Clin Radiol 67(11):1089\u20131094","journal-title":"Clin Radiol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06384-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-021-06384-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06384-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T12:34:55Z","timestamp":1661430895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-021-06384-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["6384"],"URL":"https:\/\/doi.org\/10.1007\/s00404-021-06384-1","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"18 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All were outside the work: honorarium, Chugai, textbook editorial expense, Springer, investigator meeting attendance expense, VBL Therapeutics (Ko.M.); research grant, Merck (S.M.); none for others.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"University of Southern California Institutional Review Board exemption (HS-16\u201300,481).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The manuscript\u2019s corresponding author (Ko.M.) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The National Inpatient Sample classified the race\/ethnicity, and the current study used the default grouping for analysis.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency"}}]}}